BioArctic AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	394.35	1,259	-228.52	252.64	-17.44	-139.72
Depreciation & Amortization	-	12.83	10.72	7.44	14.18	13.05
Stock-Based Compensation	-	24.04	19.33	16.14	2.76	1.57
Other Adjustments	-48.14	70.07	58.52	45.01	-39.15	3.72
Change in Receivables	677.28	-64.77	-190.56	-26.92	-2.41	-5.12
Changes in Accounts Payable	390.39	238.99	42.66	25.13	27.33	0.06
Changes in Income Taxes Payable	-160.61	-71.6	-0.52	0.16	0.34	-0.31
Changes in Unearned Revenue	-	-	-	-	-58.48	-8.47
Operating Cash Flow	1,253	1,431	-316.33	309.69	-31.64	-140.46
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-	-10.24	-26.64	-7.44	-12.75	-4.39
Other Investing Activities	-	-884.4	232.27	-500.04	-0.02	-0.03
Investing Cash Flow	-610.48	-894.65	205.63	-507.49	-12.76	-4.41
Issuance of Common Stock	-	26.01	6.02	14.98	5.99	-
Net Common Stock Issued (Repurchased)	-	26.01	6.02	14.98	5.99	-
Other Financing Activities	-	0.89	-0.33	-0.92	-8.79	-7.39
Financing Cash Flow	25.18	26.9	5.69	14.06	-2.81	-7.39
Foreign Exchange Rate Adjustments	-21.82	-35.82	6.37	-10.09	4.19	0.72
Net Cash Flow	667.97	563.32	-105.01	-183.73	-47.21	-152.26
Free Cash Flow	1,253	1,421	-342.97	302.25	-44.38	-144.84
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	106.91%	70.50%	-131.36%	48.74%	-19.41%	-542.73%
Free Cash Flow Per Share	14.15	16.01	-3.87	3.42	-0.50	-1.64
Levered Free Cash Flow	443.02	1,192	-150.86	254.53	-40.55	-119.84
Unlevered Free Cash Flow	433.03	1,195	-187.3	234.76	-46.73	-119.17